Science
Following Its 52-Week Low, Denali Therapeutics Inc. (NASDAQ: DNLI)’S Share Price Rose 41.67% And Its YTD Numbers Fell -22.20%
During the last session, Denali Therapeutics Inc. (NASDAQ:DNLI)’s traded shares were 0.57 million, with the beta value of the company hitting 1.67. At the end